Breyer, Johannes and Burger, Maximilian and Otto, Wolfgang (2016) Immunotherapy in urothelial carcinoma: fade or future standard? TRANSLATIONAL ANDROLOGY AND UROLOGY, 5 (5). pp. 662-667. ISSN 2223-4683, 2223-4691
Full text not available from this repository. (Request a copy)Abstract
Immunotherapy of non-muscle-invasive bladder carcinoma by Bacillus-Calmette-Guerin (BCG) instillation is a well-established treatment option since decades. Despite this fact, the immunocellular basis was first studied in recent years. New aspects of immunotherapy, also for progressed bladder carcinoma, might follow promising research on immunological targets.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | BACILLUS-CALMETTE-GUERIN; SUPERFICIAL BLADDER-CANCER; MITOMYCIN-C; FORMAL METAANALYSIS; RADICAL CYSTECTOMY; RANDOMIZED-TRIALS; TUMOR PROGRESSION; CELL-CARCINOMA; B7 FAMILY; HIGH-RISK; Bladder; urothelial carcinoma; Bacillus-Calmette-Guerin (BCG); immunotherapy |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Urologie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 27 Aug 2020 10:03 |
| Last Modified: | 27 Aug 2020 10:03 |
| URI: | https://pred.uni-regensburg.de/id/eprint/4155 |
Actions (login required)
 |
View Item |
